EP 0741572 A1 19961113 - AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14-g(a),17-g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17-g(b)-DIOL
Title (en)
AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14-g(a),17-g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17-g(b)-DIOL
Title (de)
MITTEL ZUR TRANSDERMALEN APPLIKATION ENTHALTEND 14-g(a),17-g(a)-ETHANOESTRA-1,3,5(10)-TRIEN-3,17-g(b)-DIOL
Title (fr)
SUBSTANCE POUR APPLICATION TRANSDERMIQUE CONTENANT DU 14-g(a),17-g(a)-ETHANOESTRA-1,3,5(10)-TRIENE-3,17-g(b)-DIOL
Publication
Application
Priority
EP 9400213 W 19940127
Abstract (en)
[origin: WO9520392A1] Described is an agent, intended for transdermal administration, which is characterized in that it contains 14 alpha ,17 alpha -ethanoestra-1,3,5(10)-triene-3,17 beta -diol, optionally in combination with one or two gestagens.
IPC 1-7
IPC 8 full level
A61K 47/28 (2006.01); A61K 9/70 (2006.01); A61K 31/565 (2006.01); A61K 31/57 (2006.01)
CPC (source: EP)
A61K 9/7061 (2013.01); A61K 9/7069 (2013.01); A61K 9/7084 (2013.01); A61K 31/565 (2013.01); A61K 31/57 (2013.01)
Citation (search report)
See references of WO 9520392A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9520392 A1 19950803; AU 5971294 A 19950815; EP 0741572 A1 19961113; FI 962993 A0 19960726; FI 962993 A 19960726; JP H09510697 A 19971028; NO 963128 D0 19960726; NO 963128 L 19960726
DOCDB simple family (application)
EP 9400213 W 19940127; AU 5971294 A 19940127; EP 94905711 A 19940127; FI 962993 A 19960726; JP 51984495 A 19940127; NO 963128 A 19960726